Evidence map›Paper›PMID 26609316›Full record

ArticleExpert review of ophthalmology2015

Retinal Gene Therapy: Current Progress and Future Prospects.

Cristy A Ku, Mark E Pennesi

Open access · greenAbstract read
In one paragraph

Article in Expert review of ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors.Molecular therapy. Methods & clinical development · 2017
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Cristy A KuCenter for Neuroscience, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, West Virginia, 26505, USA.
Mark E PennesiCasey Eye Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Oregon Health & Science University · US

Funding

Serotonin Receptor Modulation of Neurotrophic Factors in the RetinaK08EY021186 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI PENNESI, MARK E · 2011 to 2015
$824k
NEI NIH HHS K08 EY021186
6 · The paper itself

Abstract

Clinical trials treating inherited retinal dystrophy caused by

Indexed as

adeno-associated virusequine infectious anemia virusgene therapyinherited retinal dystrophiesRPE65

Identifiers

PMID26609316
PMCPMC4655604
OpenAlexW1965390190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.